Prosecution Insights
Last updated: April 19, 2026
Application No. 18/264,325

IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS

Non-Final OA §103
Filed
Aug 04, 2023
Examiner
SONG, JIANFENG
Art Unit
1613
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Givaudan SA
OA Round
1 (Non-Final)
56%
Grant Probability
Moderate
1-2
OA Rounds
2y 8m
To Grant
90%
With Interview

Examiner Intelligence

Grants 56% of resolved cases
56%
Career Allow Rate
468 granted / 834 resolved
-3.9% vs TC avg
Strong +33% interview lift
Without
With
+33.4%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
77 currently pending
Career history
911
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
48.2%
+8.2% vs TC avg
§102
8.2%
-31.8% vs TC avg
§112
18.1%
-21.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 834 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant's election with traverse of invention group I, claims 1-8, in the reply filed on 01/21/2026 is acknowledged. The traversal is on the ground(s) that special technical feature of bio-sourced ingredients containing ocimene and container. This is not found persuasive because bio-sourced ingredients contain ocimene such as lavender oil is well-known and it must be in a container. Furthermore, Mintel in the 102 rejection teaches cosmetic composition comprising lavender oil in a container. The requirement is still deemed proper and is therefore made FINAL. Claims 9-22 are withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected invention, there being no allowable generic or linking claim. Applicant timely traversed the restriction (election) requirement in the reply filed on 01/21/2026. Applicants further elect perfume as specific product, ocimene as specific bio-resourced ingredient, prenylthiol as specific thiol compound, and hydrogen peroxide as specific malodour-counteracting agent. For compact prosecution purpose, the election of spices requirement is withdrawn. Claims 1-22 are pending, claims 1-8 are under examination. Priority Acknowledge is made that this application is national stage of internation patent application PCT/EP2021/084437, filed on 12/06/2021; which claims priority from European Patent application EP21155289.8, filed on 02/04/2021. Information Disclosure Statement The information disclosure statement (IDS) submitted on 08/04/2023 is being considered by the examiner. Claims Objection Claims 2-8 are objected for starting from “A”. Dependent claims 2-8 should start from “The”. Proper correction is required. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1-6 and 8 are rejected under 35 U.S.C. 103 as being unpatentable over Mintel (“Fresh Fix Hydrating Mist to Go”, 12/22/2008; cited in IDS). Determination of the scope and content of the prior art (MPEP 2141.01) Mintel teaches a container filled with hydrating mist (skin care cosmetic) comprising lavender oil (comprising ocimene as indicated by claim 3) and hydrogen peroxide. Ascertainment of the difference between the prior art and the claims (MPEP 2141.02) The difference between the instant application and Mintel is that Mintel is not specific enough for anticipating. Finding of prima facie obviousness Rational and Motivation (MPEP 2142-2143) It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to produce the instant invention. The limitation of claims 1-6 and 8 are met by Mintel teaches a container filled with hydrating mist (skin care cosmetic) comprising lavender oil (comprising ocimene as indicating by claim 3) and hydrogen peroxide, obviously, there is a step that hydrogen peroxide is being mixed into the composition comprising lavender oil (including ocimene), and this step read on the limitation of treating the product (hydrating mist cosmetic product) with malodour-counteracting agent (hydrogen peroxide) in claim 1. Mintel is silent about suppressing or eliminating a malodour from the product as well as “prevents contact of ocimene with material in the container capable of reacting with ocimene to generate a thiol compound (prenylthiol)” which are regarded as inherency of prior art process. In summary, although the reference is silent about all the functional properties instantly claimed, it does not appear that the claim language or limitations result in a manipulative difference in the method steps when compared to the prior art disclosure. See Bristol-Myers Squibb Company v. Ben Venue Laboratories, 58 USPQ2d 1508 (CAFC 2001). “It is a general rule that merely discovering and claiming a new benefit of an old process cannot render the process again patentable.” In re Woodruff, 16 USPQ2d 1934, 1936 (Fed. Cir. 1990). Granting a patent on the discovery of an unknown but inherent function would remove from the public that which is in the public domain by virtue of its inclusion in, or obviousness from, the prior art. In re Baxter Travenol Labs, 21 USPQ2d 1281 (Fed. Cir. 1991). See M.P.E.P. 2145. On this record, it is reasonable to conclude that the same cosmetic product is being treated with the same hydrogen peroxide by the same process in both the instant claims and the prior art reference. The fact that Applicant may have discovered yet another beneficial effect from the method set forth in the prior art does not mean that they are entitled to receive a patent on that method. Thus, prior art teaches, either expressly or inherently implied, each and every limitation of the instant claims. it remains the Examiner's position that the instantly claimed method is obvious. In light of the forgoing discussion, the Examiner concludes that the subject matter defined by the instant claims would have been obvious within the meaning of 35 USC 103. From the teachings of the references, it is apparent that one of ordinary skill in the art would have had a reasonable expectation of success in producing the claimed invention. Therefore, the invention as a whole was prima facie obvious to one of ordinary skill in the art before the effective filing date of the claimed invention, as evidenced by the references, especially in the absence of evidence to the contrary. Claims 7 is rejected under 35 U.S.C. 103 as being unpatentable over Mintel (“Fresh Fix Hydrating Mist to Go”, 12/22/2008; cited in IDS), as applied for the above 103 rejection for claims 1-6 and 8, in view of Py (US20100140290). Determination of the scope and content of the prior art (MPEP 2141.01) Mintel teaching has already been discussed in the above 103 rejection and is incorporated herein by reference. Py teaches A device and method for aseptically storing and dispensing a liquid. The device has container forming a variable-volume storage chamber, and a one-way valve coupled in fluid communication with the storage chamber and having an elastic valve member forming a normally closed valve opening (abstract). The container is sterilized for cosmetic product in one embodiment ([0055, 0058]). In an alternate filling method, a sterile environment is not required even though the product needs to be maintained in a sterile environment. Filling may include injecting a sterilizing agent such as liquid hydrogen peroxide at a pressure above atmospheric into containers made of polyethylene terephthalate or other suitable material for sterilization thereof. To remove the sterilizing agent, a stream of hot sterile air can hasten evaporation thereof. Then, the sterile product can fill the container and displace the hot air until a portion of the sterile fluid can be suctioned away to insure the entire contents are sterile. At such time, the proper closure in the form of a sterilized nozzle can be applied. For further examples of acceptable filling methods and apparatus, the container may be filled in accordance with the teachings of U.S. Pat. No. 6,351,924, U.S. Pat. No. 6,372,276 and/or U.S. Pat. No. 6,355,216, each of which is incorporated herein by reference in its entirety ([0071]). Ascertainment of the difference between the prior art and the claims (MPEP 2141.02) The difference between the instant application and Mintel is that Mintel do not expressly teach pretreating container with hydrogen peroxide. This deficiency in Mintel is cured by the teachings of Py. Finding of prima facie obviousness Rational and Motivation (MPEP 2142-2143) It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Mintel, as suggested by Py, and produce the instant invention. One of ordinary skill in the art would have been motivated to pre-treat container with hydrogen peroxide because this is known process for sterilizing container for cosmetic composition as suggested by Py. Since it is advantage to have sterilized container to avoid contamination before cosmetic composition being brought into container, it is obvious to pre-treat container with hydrogen peroxide and produce instant claimed invention with reasonable expectation of success. In light of the forgoing discussion, the Examiner concludes that the subject matter defined by the instant claims would have been obvious within the meaning of 35 USC 103. From the teachings of the references, it is apparent that one of ordinary skill in the art would have had a reasonable expectation of success in producing the claimed invention. Therefore, the invention as a whole was prima facie obvious to one of ordinary skill in the art before the effective filing date of the claimed invention, as evidenced by the references, especially in the absence of evidence to the contrary. Conclusion No claim is allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JIANFENG SONG. Ph.D. whose telephone number is (571)270-1978. The examiner can normally be reached M-F 8-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Brian-Yong Kwon can be reached at (571)272-0581. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JIANFENG SONG/Primary Examiner, Art Unit 1613
Read full office action

Prosecution Timeline

Aug 04, 2023
Application Filed
Mar 23, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599562
NANOCRYSTAL MICROPARTICLES OF POORLY SOLUBLE DRUGS AND METHODS OF PRODUCTION AND USE THEREOF
2y 5m to grant Granted Apr 14, 2026
Patent 12599564
ANTIDIABETIC PHARMACEUTICAL COMPOSITIONS
2y 5m to grant Granted Apr 14, 2026
Patent 12599569
ENCAPSULATED RESVERATROL (RSV) NANOPARTICLES
2y 5m to grant Granted Apr 14, 2026
Patent 12594238
LOW HYGROSCOPICITY ACTIVE POWDER COMPOSITIONS
2y 5m to grant Granted Apr 07, 2026
Patent 12582589
COMPOSITIONS AND METHODS FOR EYELASHES
2y 5m to grant Granted Mar 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
56%
Grant Probability
90%
With Interview (+33.4%)
2y 8m
Median Time to Grant
Low
PTA Risk
Based on 834 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month